Effects of lipid-lowering drugs on reverse cholesterol transport gene expressions in peripheral blood mononuclear and HepG2 cells.
about
Role of liver X receptors in cholesterol efflux and inflammatory signaling (review)Serum CETP status is independently associated with reduction rates in LDL-C in pitavastatin-treated diabetic patients and possible involvement of LXR in its associationDanthron activates AMP-activated protein kinase and regulates lipid and glucose metabolism in vitro.Statin-induced decrease in ATP-binding cassette transporter A1 expression via microRNA33 induction may counteract cholesterol efflux to high-density lipoprotein.ABCA1 and ABCG1 expressions are regulated by statins and ezetimibe in Caco-2 cells.
P2860
Effects of lipid-lowering drugs on reverse cholesterol transport gene expressions in peripheral blood mononuclear and HepG2 cells.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Effects of lipid-lowering drug ...... d mononuclear and HepG2 cells.
@en
Effects of lipid-lowering drug ...... d mononuclear and HepG2 cells.
@nl
type
label
Effects of lipid-lowering drug ...... d mononuclear and HepG2 cells.
@en
Effects of lipid-lowering drug ...... d mononuclear and HepG2 cells.
@nl
prefLabel
Effects of lipid-lowering drug ...... d mononuclear and HepG2 cells.
@en
Effects of lipid-lowering drug ...... d mononuclear and HepG2 cells.
@nl
P2093
P2860
P356
P1433
P1476
Effects of lipid-lowering drug ...... d mononuclear and HepG2 cells.
@en
P2093
Alvaro Cerda
Egidio Lima Dorea
Fabiana Dalla Vecchia Genvigir
Maria Alice Vieira Willrich
Mario Hiroyuki Hirata
Márcia Martins Bernik
Raquel Oliveira
Rosario Dominguez Crespo Hirata
Simone Sorkin Arazi
P2860
P304
P356
10.2217/PGS.10.93
P577
2010-09-01T00:00:00Z